10 years of Synovo
Posted on
Synovo 10 years anniversary on Nov 2014 was a total success. Thank you!
Orphan designation for pancreatic cancer
Posted on
Orphan designation for SYD003 for the treatment of pancreatic cancer. Granted by the European Medicines Agency (EMA) on 22 August 2014 and by the US Food and Drug Administration (FDA) on 20 October 2014.
Orphan designation for treatment of CF
Posted on
Our compound SYD0073 has been granted orphan designation (EU/3/14/1239) by the European Medicines Agency (EMA) for the treatment of cystic fibrosis.